Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Belite Bio Inc
BLTE | US
137.23
USD2.30
1.70%
BLTE | US
About Belite Bio Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
03/06/2026
Close
137.23
Open
135.09
High
137.82
Low
132.95
Belite Bio Inc a clinical stage biopharmaceutical drug development company engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases (STGD1). Its lead product candidate is LBS-008 (Tinlarebant) an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in STGD1 and GA patients. The company is also developing LBS-009 an anti-retinol binding protein 4 oral therapy targeting liver disease including non-alcoholic fatty liver disease nonalcoholic steatohepatitis type 2 diabetes and gout which is in the preclinical development phase. Belite Bio Inc was founded in 2016 and is based in San Diego California. Belite Bio Inc operates as a subsidiary of Lin Bioscience International Ltd.
View LessBLTE | US
Risk
46.4
Sharpe
2.04
Luna's Score
49/100
Recommendation
Hold
Luna says (BLTE | US)
What's Working
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
62.7%1 month
46.4%3 months
46.6%6 months
45.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
15.21
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-35.61
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-36.54M
MarketCap
4.20B
MarketCap(USD)
4.20B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-41.44
Short ratio
8.66
Short perc.
2.16
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
21.41
Range1M
28.95
Range3M
53.37
Volumes: Market Activity
Rel. volume
0.82
Price X volume
22.75M
